Skip to main content
Top
Published in: Virology Journal 1/2007

Open Access 01-12-2007 | Commentary

The PB1-F2 protein of Influenza A virus: increasing pathogenicity by disrupting alveolar macrophages

Author: J Robert Coleman

Published in: Virology Journal | Issue 1/2007

Login to get access

Abstract

With the prospect of another pandemic Influenza fresh in our consciousness, the pathogenic nature of the Influenza A virus and its ability to induce high rates of mortality are ever more pertinent. Recently a novel protein encoded by an alternate reading frame in the PB1 Gene segment of Influenza A virus has been discovered and in turn shown to enhance viral virulence in a mouse model [1]. This protein has been shown to specifically target and destroy alveolar macrophages [2]. This review suggests that this protein, present in all previous pandemic strains, may reappear as a virulence factor in a subsequent pandemic strain. This PB1-F2 protein will enhance the mortality rate of the virus by increasing the likelihood of a secondary bacterial infection, which is the primary cause of death to a patient infected with Influenza A.
Appendix
Available only for authorised users
Literature
1.
2.
go back to reference Chen W: A novel influenza A virus mitochondrial protein that induces cell death. Nat Med 2001,7(12):1306-12. 10.1038/nm1201-1306PubMedCrossRef Chen W: A novel influenza A virus mitochondrial protein that induces cell death. Nat Med 2001,7(12):1306-12. 10.1038/nm1201-1306PubMedCrossRef
4.
go back to reference Neznanov N, et al.: Proteolytic cleavage of the p65-RelA subunit of NF-kappaB during poliovirus infection. J Biol Chem 280(25):24153-8. 2005 Jun 24; Epub 2005 Apr 21 10.1074/jbc.M502303200 Neznanov N, et al.: Proteolytic cleavage of the p65-RelA subunit of NF-kappaB during poliovirus infection. J Biol Chem 280(25):24153-8. 2005 Jun 24; Epub 2005 Apr 21 10.1074/jbc.M502303200
5.
go back to reference Salvatore M, et al.: Effects of influenza A virus NS1 protein on protein expression: the NS1 protein enhances translation and is not required for shutoff of host protein synthesis. J Virol 2002,76(3):1206-12.PubMedPubMedCentralCrossRef Salvatore M, et al.: Effects of influenza A virus NS1 protein on protein expression: the NS1 protein enhances translation and is not required for shutoff of host protein synthesis. J Virol 2002,76(3):1206-12.PubMedPubMedCentralCrossRef
6.
go back to reference Steinhauer DA, et al.: Genetics of influenza virus. Annu Rev Genet 2002, 36: 305-332. 10.1146/annurev.genet.36.052402.152757PubMedCrossRef Steinhauer DA, et al.: Genetics of influenza virus. Annu Rev Genet 2002, 36: 305-332. 10.1146/annurev.genet.36.052402.152757PubMedCrossRef
7.
go back to reference Russell CJ, et al.: The genesis of a pandemic influenza virus. Cell 2005, 123: 368-371. 10.1016/j.cell.2005.10.019PubMedCrossRef Russell CJ, et al.: The genesis of a pandemic influenza virus. Cell 2005, 123: 368-371. 10.1016/j.cell.2005.10.019PubMedCrossRef
8.
go back to reference Zamarin D, et al.: Influenza virus PB1-F2 protein induces cell death through mitochondrial ANT3 and VDAC1. PLoS Pathog 2005,1(1):e4. Epub 2005 Sep 30 10.1371/journal.ppat.0010004PubMedPubMedCentralCrossRef Zamarin D, et al.: Influenza virus PB1-F2 protein induces cell death through mitochondrial ANT3 and VDAC1. PLoS Pathog 2005,1(1):e4. Epub 2005 Sep 30 10.1371/journal.ppat.0010004PubMedPubMedCentralCrossRef
9.
go back to reference Sethi S: Bacterial pneumonia. Managing a deadly complication of influenza in older adults with comorbid disease. Geriatrics 2002,57(3):56-61.PubMed Sethi S: Bacterial pneumonia. Managing a deadly complication of influenza in older adults with comorbid disease. Geriatrics 2002,57(3):56-61.PubMed
11.
go back to reference Thompson WW, et al.: Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003, 289: 179-186. 10.1001/jama.289.2.179PubMedCrossRef Thompson WW, et al.: Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003, 289: 179-186. 10.1001/jama.289.2.179PubMedCrossRef
12.
go back to reference Cram P, et al.: Influenza: Cost of illness and considerations in the economic evaluation of new and emerging therapies. Pharmacoeconomics 2001, 19: 223-230. 10.2165/00019053-200119030-00001PubMedCrossRef Cram P, et al.: Influenza: Cost of illness and considerations in the economic evaluation of new and emerging therapies. Pharmacoeconomics 2001, 19: 223-230. 10.2165/00019053-200119030-00001PubMedCrossRef
13.
go back to reference Neuman G, et al.: Orthomyxovirus replication, transcription, and polyadenylation. Curr Top Microbiol Immunol 2004, 283: 121-43. Neuman G, et al.: Orthomyxovirus replication, transcription, and polyadenylation. Curr Top Microbiol Immunol 2004, 283: 121-43.
14.
go back to reference Belay ED: Reye's syndrome in the United States from 1981 through 1997. N Engl J Med 340(18):1377-82. 1999 May 6; 10.1056/NEJM199905063401801 Belay ED: Reye's syndrome in the United States from 1981 through 1997. N Engl J Med 340(18):1377-82. 1999 May 6; 10.1056/NEJM199905063401801
15.
go back to reference Bergen GA, et al.: Influenza. More than mom and chicken soup. J Fla Med Assoc 1996,83(1):19-22.PubMed Bergen GA, et al.: Influenza. More than mom and chicken soup. J Fla Med Assoc 1996,83(1):19-22.PubMed
16.
go back to reference Chilvers MA: Local mucociliary defence mechanisms. Paediatr Respir Rev 2000,1(1):27-34. 10.1053/prrv.2000.0009PubMed Chilvers MA: Local mucociliary defence mechanisms. Paediatr Respir Rev 2000,1(1):27-34. 10.1053/prrv.2000.0009PubMed
17.
18.
19.
go back to reference Sibille Y, et al.: Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am Rev Respir Dis 1990, 141: 471-501.PubMedCrossRef Sibille Y, et al.: Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am Rev Respir Dis 1990, 141: 471-501.PubMedCrossRef
20.
go back to reference Martin TR: Recognition of bacterial endotoxin in the lungs. Am J Respir Cell Mol Biol 2000, 23: 128-132.PubMedCrossRef Martin TR: Recognition of bacterial endotoxin in the lungs. Am J Respir Cell Mol Biol 2000, 23: 128-132.PubMedCrossRef
21.
go back to reference Medzhitov R, et al.: Decoding the Patterns of Self and Nonself by the Innate Immune System. Science 296(5566):298-300. 12 April 2002 10.1126/science.1068883 Medzhitov R, et al.: Decoding the Patterns of Self and Nonself by the Innate Immune System. Science 296(5566):298-300. 12 April 2002 10.1126/science.1068883
22.
go back to reference Goldsby R, et al.: Kuby Immunology Cp2. 4th edition. W.H. Freeman And Company, New York; 2001:27. Goldsby R, et al.: Kuby Immunology Cp2. 4th edition. W.H. Freeman And Company, New York; 2001:27.
23.
24.
go back to reference Jackson RJ: Alternative mechanisms of initiating translation of mammalian mRNAs. Biochem Soc Trans 2005,33(Pt 6):1231-41.PubMedCrossRef Jackson RJ: Alternative mechanisms of initiating translation of mammalian mRNAs. Biochem Soc Trans 2005,33(Pt 6):1231-41.PubMedCrossRef
25.
go back to reference Gibbs JS: The influenza A virus PB1-F2 protein targets the inner mitochondrial membrane via a predicted basic amphipathic helix that disrupts mitochondrial function. J Virol 2003,77(13):7214-24. 10.1128/JVI.77.13.7214-7224.2003PubMedPubMedCentralCrossRef Gibbs JS: The influenza A virus PB1-F2 protein targets the inner mitochondrial membrane via a predicted basic amphipathic helix that disrupts mitochondrial function. J Virol 2003,77(13):7214-24. 10.1128/JVI.77.13.7214-7224.2003PubMedPubMedCentralCrossRef
26.
go back to reference Yamada H, et al.: Mitochondrial targeting sequence of the influenza A virus PB1-F2 protein and its function in mitochondria. FEBs Lett 578(3):331-6. 2004 Dec 17 10.1016/j.febslet.2004.11.017 Yamada H, et al.: Mitochondrial targeting sequence of the influenza A virus PB1-F2 protein and its function in mitochondria. FEBs Lett 578(3):331-6. 2004 Dec 17 10.1016/j.febslet.2004.11.017
27.
go back to reference Chanturiya N: PB1-F2, an influenza A virus-encoded proapoptotic mitochondrial protein, creates variably sized pores in planar lipid membranes. J Virol 2004,78(12):6304-12. 10.1128/JVI.78.12.6304-6312.2004PubMedPubMedCentralCrossRef Chanturiya N: PB1-F2, an influenza A virus-encoded proapoptotic mitochondrial protein, creates variably sized pores in planar lipid membranes. J Virol 2004,78(12):6304-12. 10.1128/JVI.78.12.6304-6312.2004PubMedPubMedCentralCrossRef
28.
go back to reference Obenauer JC, et al.: Large-scale sequence analysis of avian influenza isolates. 311(5767):1576-80. 2006 Mar 17 Epub 2006 Jan 26 Obenauer JC, et al.: Large-scale sequence analysis of avian influenza isolates. 311(5767):1576-80. 2006 Mar 17 Epub 2006 Jan 26
29.
go back to reference World Health Organization, Epidemic and Pandemic Alert and Response (EPR) Avian Influenza 5 December 2005 World Health Organization, Epidemic and Pandemic Alert and Response (EPR) Avian Influenza 5 December 2005
Metadata
Title
The PB1-F2 protein of Influenza A virus: increasing pathogenicity by disrupting alveolar macrophages
Author
J Robert Coleman
Publication date
01-12-2007
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2007
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-4-9

Other articles of this Issue 1/2007

Virology Journal 1/2007 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.